Announcements Trials
Browse Landscape

Status

Unknown 1Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Neoplasms 518Breast Neoplasms 454Lung Neoplasms 252Prostatic Neoplasms 234Colorectal Neoplasms 216Carcinoma, Non-Small-Cell Lung 185Pancreatic Neoplasms 154Carcinoma, Hepatocellular 136Stomach Neoplasms 134Ovarian Neoplasms 116Multiple Myeloma 98Melanoma 93Head and Neck Neoplasms 92Esophageal Neoplasms 90Disease 87Urinary Bladder Neoplasms 85Uterine Cervical Neoplasms 78Lymphoma 78Brain Neoplasms 75Liver Neoplasms 74Hematologic Neoplasms 74Endometrial Neoplasms 71Leukemia, Myeloid, Acute 66Neoplasm Metastasis 65Colonic Neoplasms 61Rectal Neoplasms 59Precursor Cell Lymphoblastic Leukemia-Lymphoma 56Glioma 54Sarcoma 53Leukemia 53

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Observational × HER2-positive Metastatic Breast Cancer × Clear all
NCT06551116 2026-04-07

QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

Abramson Cancer Center at Penn Medicine

Recruiting
200 enrolled
Breast

HER2-positive Metastatic Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡